Cresud is a pharmaceutical preparations company trading on NASDAQ, led by CEO Alejandro Gustavo Elsztain.
Common questions about Cresud
Cresud is scheduled to report earnings for Q3 2026 on May 8, 2026.
Cresud has approximately 2,706 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.